Localized Breast Cancer 2024 UPDATE

Localized Breast Cancer 2024 UPDATE

Up next

ctDNA, Liquid Biopsies, Methylation, NGS: What Does It All Mean?

This week’s episode we are very excited to welcome a special guest Dr. Hatim Husain, MD, a medical oncologist and physician-scientist at UC San Diego Moores Cancer Center, whose clinical and research expertise focuses on lung cancer and precision oncology. We cover the topic of l ...  Show more

Metastatic Non-Small Cell Lung Cancer 2026 UPDATE

This week's episode focuses on metastatic non-small cell lung cancer - the quickly growing and changing systemic therapy landscape, including traditional chemotherapy, immunotherapy, and targeted agents. Since our last recording the number of FDA-approved targeted drugs has signi ...  Show more

Recommended Episodes

7. Breast cancer
Surgery 101

In this episode, Dr Parveen Boora discusses breast cancer. Topics covered include: approach to the history and physical exam of breast masses indications for breast imaging and biopsy staging invasive cancer management of breast cancer surgery for primary tumors surgery for axill ...  Show more

Wellness Matters | Redefining Breast Cancer Diagnosis & Treatment
Wellness Matters

Get ready for an insightful conversation in the second episode of Wellness Matters by American Hospital Dubai! We dive into how oncoplastic surgery, paired with cutting-edge seed technology, is transforming breast cancer treatment. This advancement is making tumor detection more ...  Show more

143. San Antonio Breast Cancer Symposium 2024 - Part 2
Oncology for the Inquisitive Mind

Our second SABCS (San Antonio Breast Cancer Symposium) episode covers everything (else) you need to know from 2024.


In this episode, we dive into the role of trastuzumab deruxtecan in HR +ve, HER2 low cancers, perioperative atezolizumab in tnbc, the use of a novel A ...

  Show more

Treatment De-escalation for Favorable Risk Breast Cancer
JCO Oncology Practice Podcast

Dr. Chino talks with Dr. Atif Khan and Dr. Lola Fayanju about the shift in breast cancer management from reducing locoregional recurrence and improving breast cancer mortality to deintensification, shared decision making, and improved quality of life. This discussion will be base ...  Show more